ETF Holdings Breakdown of MNMD

News associated with MNMD

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Shares Bought by Wells Fargo & Company MN

Wells Fargo & Company MN raised its stake in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Free Report) by 61.8% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 39,974 shares of the company’s stock after purchasing an additional 15,269 shares during the period. Wells Fargo & Company MN’s […] - 2025-05-07 07:18:53

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Shares Sold by Legal & General Group Plc

Legal & General Group Plc cut its holdings in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Free Report) by 8.8% during the fourth quarter, HoldingsChannel reports. The fund owned 58,437 shares of the company’s stock after selling 5,639 shares during the period. Legal & General Group Plc’s holdings in Mind Medicine (MindMed) were worth $407,000 at […] - 2025-04-30 07:54:53

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives $25.11 Consensus Target Price from Brokerages

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Get Free Report) has been given an average rating of “Buy” by the thirteen ratings firms that are presently covering the firm, MarketBeat reports. Ten investment analysts have rated the stock with a buy rating and three have assigned a strong buy rating to the company. The average 12-month […] - 2025-04-23 05:30:49

Bank of New York Mellon Corp Boosts Stock Position in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)

Bank of New York Mellon Corp boosted its holdings in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Free Report) by 5.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 200,121 shares of the company’s stock after buying an additional 10,338 shares during the quarter. […] - 2025-03-24 07:08:53

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives $26.33 Consensus Price Target from Brokerages

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Get Free Report) has received a consensus rating of “Buy” from the thirteen ratings firms that are covering the company, Marketbeat Ratings reports. Ten investment analysts have rated the stock with a buy recommendation and three have assigned a strong buy recommendation to the company. The average twelve-month target […] - 2025-03-04 06:22:57

Analysts Set Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) PT at $26.33

Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Get Free Report) have received a consensus recommendation of “Buy” from the thirteen research firms that are currently covering the stock, MarketBeat reports. Ten investment analysts have rated the stock with a buy rating and three have assigned a strong buy rating to the company. The average […] - 2025-02-07 06:32:50

China Universal Asset Management Co. Ltd. Buys Shares of 15,549 Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)

China Universal Asset Management Co. Ltd. bought a new stake in shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Free Report) in the fourth quarter, Holdings Channel reports. The fund bought 15,549 shares of the company’s stock, valued at approximately $108,000. A number of other hedge funds have also made changes to their positions in […] - 2025-02-04 09:46:56

MNMD institutional holdings

Date	ETF ISIN/Name	Num Shares	Book value
2025-05-08	IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc)	54,931	USD 354,854
2025-05-08	IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc))	1,761	USD 11,376
2025-05-08	IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc))	36,405	USD 235,176
2025-05-08	IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist))	36,405	USD 235,176 -2.0%
Total =		129,502	USD 836,582

Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer